A bradykinin antagonist abolishes beneficial effect of captopril on duration of survival after acute coronary artery ligation in hypertensive rats

Pharmacological Research

Volumn 52, Issue 3, 2005, Pages 211-215

  Sharma, Jagdish N ^a   Abbas, S Atif ^b  

^a KUWAIT UNIVERSITY   (Kuwait)

^b SCHOOL OF PHARMACEUTICAL SCIENCES   (Malaysia)

Author keywords

Captopril; Coronary artery ligation; Hypertensive rats; Kinin antagonist; Survival; Time

Indexed keywords

BRADYKININ ANTAGONIST; CAPTOPRIL; DEXTRO ARGINYLBRADYKININ[3 HYDROXYPROLINE 7 DEXTRO PHENYLALANINE]; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DIASTOLIC BLOOD PRESSURE; HEART PROTECTION; HEART RATE; HYPERTENSION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SURVIVAL TIME; SYSTOLIC BLOOD PRESSURE;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BLOOD PRESSURE; BRADYKININ; CAPTOPRIL; CORONARY VESSELS; HEART RATE; HYPERTENSION; LIGATION; MALE; RATS; RATS, INBRED SHR; RECEPTOR, BRADYKININ B2; SURVIVAL RATE;

EID: 22144446729     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phrs.2005.03.005     Document Type: Article

References (26)

1. J.N. Sharma Interrelationship between the kallikrein-kinin system and hypertension Gen Pharmacol 19 1988 177 187
2. J.N. Sharma Does the kinin system mediate in the cardiovascular abnormality? An overview J Clin Pharmacol 43 2003 1187 1195
3. J.N. Sharma, and J. Sharma Cardiovascular properties of the kallikrein-kinin system Curr Med Res Opin 18 2002 10 17
4. J.N. Sharma, K. Uma, A.R. Noor, and A.R. Rahman Blood pressure regulation by the kallikrein-kinin system Gen Pharmacol 27 1996 55 63
5. A. Vegh, L. Szekeres, and J.R. Parratt Local intracoronary infusion of bradykinin profoundly reduces the severity of ischaemia-induced arrhythmia in anaesthetized dogs Br J Pharmacol 104 1991 294 295
6. W. Linz, G. Wiemer, P. Gohlke, T. Unger, and B.A. Scholken Contribution of kinins to the cardiovascular actions of angiotensin converting enzyme inhibitors Pharmacol Rev 47 1995 25 49
7. S.A. Abbas, J.N. Sharma, and A.P.M. Yusof Effect of bradykinin and its antagonist on survival time after coronary artery occlusion in rats Gen Pharmacol 33 1999 243 247
8. S.A. Abbas, J.N. Sharma, and A.P.M. Yusof The effect of bradykinin and its antagonist on survival time after coronary artery occlusion in hypertensive rats Immunopharmacology 44 1999 93 98
9. H. Yoshida, J.J. Zhang, L. Chao, and J. Chao Kallikrein gene delivery attenuates myocardial infarction and apoptosis after myocardial ischemia and reperfusion Hypertension 35 2000 25 31
10. H. Selye, E. Bajusz, S. Grassos, and P. Mendell Simple techniques for the surgical occlusion of coronary vessels in rats Angiology 11 1960 398 407
11. J.N. Sharma, J.M. Stewart, S.S.J. Mohsin, M. Katori, and R. Vavrek Influence of a kinin antagonist on acute hypotensive responses induced by bradykinin and captopril in spontaneously hypertensive rats Agents Actions 33/III 1992 258 269
12. R.J. Marshall, A.W. Muir, and E. Winslow Development of severe model of early coronary artery ligation-induced dysrrhythmia in anaesthetized rat Br J Pharmacol 73 1981 951 959
13. S.J. Coker Is the antiarrhythmic activity of ACE inhibitor due to reduce angiotensin or increased bradykinin? J Mol Cell Cardiol 24 Suppl. V 1992 S115
14. S.S.J. Mohsin, M. Majima, M. Katori, and J.N. Sharma Important suppressive roles of the kallikrein-kinin system during the developmental stage of hypertension in spontaneously hypertensiove rats Asia Pacific J Pharmacol 7 1992 73 82
15. E. Agabiti-Rosei, E. Ambrosioni, C.P. Palu, M. Muiesan, and A. Zanchetti ACE inhibitor ramipril is more effective that beta-blocker atenolol in reducing left ventricular mass in hypertension. Result of the RACE (ramipril cardoprotective evaluation) study on behalf of the RACE study group J Hypertens 13 1995 1325
16. E. Braunwald ACE inhibitors - a cornerstone of the treatment of heart failure N Engl J Med 325 1991 351 353
17. M.A. Pfeffer, and E. Braunwald Ventricular enlargement infarction is a modifiable process Am J Cardiol 68 1991 127 131
18. Z. Ebrahim, G.F. Baxter, and D.M. Yellon Omapatrilat limits infarct size and lowers the threshold for induction of myocardial preconditioning through a bradykinin receptor-mediated mechanism Cardiovasc Drugs Ther 18 2004 127 134
19. K.K. Veeravalli, A. Akula, and M.K. Kota Nitric oxide and prostaglandin-mediated cardioprotection by bradykinin in myocardial ischemia and perfusion injury Pol J Pharmacol 55 2003 1021 1029
20. O. Oldenburg, Q. Qin, T. Krieg, X.M. Yang, S. Philipp, and S.D. Critz Bradykinin induces mitochondrial ROS generation via NO, cGMP, PKG and mitoKATP channel opening and leads to cardioprotection Am J Physiol 286 2004 H468 H476
21. J.N. Sharma, and K. Uma Cardiac kallikrein in hypertensive rats with and without diabetes Immunopharmacology 33 1996 341 343
22. J.N. Sharma, K. Uma, and A.P.M. Yusof Left ventricular hypertrophy and its relation to the cardiac kinin-forming system in hypertensive and diabetic rats Int J Cardiol 63 1998 229 235
23. J.N. Sharma, K. Uma, and A.P.M. Yusof Altered cardiac tissue and plasma kininogen levels in hypertensive and diabetic rats Immunopharmacology 34 1999 129 132
24. T.M. Wall, R. Sheehy, and J.C. Hartman Role of bradykinin in myocardial preconditioning J Pharmacol Exp Ther 270 1994 681 689
25. A. Vegh, J.G. Rapp, and J.R. Parratt attenuation of the antiarrhythmic effects of ischemia preconditioning by blocked of bradykinin B2 receptors Br J Pharmacol 107 1994 1167 1172
26. J.N. Sharma, and U. Kesavarao Effect of captopril on urinary kallikrein, blood pressure and myocardial hypertrophy in diabetic spontaneously hypertensive rats Pharmacology 64 2002 196 200